ArticleMolecular cancer2026

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Fanhong Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.